Midcap Pharma Company Marksans Pharma Sees Decline in Stock Price, 'Hold' Call by MarketsMOJO

Marksans Pharma, a midcap pharmaceutical company, has recently seen a decline in its stock price. On October 7th, 2024, the company's stock lost -5.12%, underperforming the sector by -3.78%. This has led to a 'Hold' call by MarketsMOJO.

The stock has been on a downward trend for the past three days, with a consecutive fall of -7.82% during this period. On the same day, the stock touched an intraday low of Rs 276.15, a decrease of -4.21%. However, the stock's moving averages are still higher than the 50-day, 100-day, and 200-day moving averages, but lower than the 5-day and 20-day moving averages.

In comparison to the Sensex performance, Marksans Pharma's 1-day performance is -4.70%, while the Sensex has seen a minimal increase of 0.01%. Over the past month, the company's stock has shown a positive performance of 4.47%, while the Sensex has seen a slightly higher increase of 0.64%.

It is important to note that this article is based on factual information and does not include any external data or sources. As a midcap pharmaceutical company, Marksans Pharma's stock performance may fluctuate, and it is always recommended to do thorough research before making any investment decisions.